A jury is ordering Novartis Pharmaceuticals Corp. to pay plaintiff Barbara Davids $ 10.45 million
for osteonecrosis of the jaw injuries she says she sustained because she took the drug Zometa.
Not exact matches
Although this may seem like a negligible number of personal injury lawsuits
for a company as large as Merck & Co., experts believe that it is only the beginning and expect the filing of hundreds, if not thousands more claims as more cases of
osteonecrosis come to light.
The Fosamax side effect that has been singled out
for legal action is the development of a serious bone condition called
osteonecrosis of the jaw (ONJ), or «dead jaw.»
Boles developed
osteonecrosis of the jaw after taking the medication
for several years.